Warning: foreach() argument must be of type array|object, bool given in /var/www/html/web/app/themes/studypress-core-theme/template-parts/header/mobile-offcanvas.php on line 20

Might it make sense someday to sequence every newborn's genome at the time of birth? What are the potential advantages and concerns of this approach?

Short Answer

Expert verified
Short answer: Sequencing every newborn's genome could offer advantages such as early identification of genetic disorders, personalized medicine, preventative care, and advancements in genetic research. However, concerns and ethical issues include privacy and confidentiality, psychological impact, limited understanding of genetics, and economic considerations. The decision to implement universal genome sequencing would require careful evaluation of these pros and cons, technological advancements, and adequate privacy protections.

Step by step solution

01

Introduction to Genome Sequencing

Genome sequencing is the process of determining the complete DNA sequence of an organism's genome at a single time. This information can provide valuable insight into an individual's genetic makeup, including the risk for certain diseases, genetic disorders, and other inherited traits.
02

Potential Advantages

There are several potential advantages to genome sequencing for every newborn: 1. Early identification of genetic disorders: Sequencing a newborn's genome can help identify genetic disorders at an early stage, which could allow for early intervention, treatment, or management of the condition. 2. Personalized medicine: Knowledge of a person's genetic makeup can lead to better, more personalized medical care, as doctors can tailor treatments and medications specific to an individual's genetic profile. 3. Preventative care: Identifying genetic predispositions to certain diseases or conditions can help individuals adopt preventative measures and lifestyle changes to reduce their risk. 4. Advancements in genetic research: A larger database of sequenced genomes could contribute to increased understanding of human genetics and potentially lead to new discoveries, treatments, or cures.
03

Concerns and Ethical Issues

While there may be potential advantages to genome sequencing for newborns, there are also concerns and ethical issues that need to be considered: 1. Privacy and confidentiality: Storing and managing a vast amount of personal genetic data poses significant privacy risks, and ensuring confidentiality would be crucial to avoid misuse or discrimination based on genetic information. 2. Psychological impact: Early knowledge of genetic risks could cause unnecessary anxiety or distress for families and potentially create a self-fulfilling prophecy where individuals become overly concerned or obsessed with a condition they may never actually develop. 3. Limited understanding of genetics: Although we understand the role of certain genes in various diseases, genetics is complex, and many traits and conditions are influenced by multiple genes as well as environmental factors. Thus, genetic information may have limitations in predicting health outcomes. 4. Economic considerations: The cost of implementing universal genome sequencing may be substantial, and decisions would need to be made regarding who bears the cost and how resources are allocated. In conclusion, while sequencing every newborn's genome at the time of birth has potential advantages, it also raises concerns and ethical issues that need to be carefully considered. The decision to implement such a practice would require a thorough evaluation of the pros and cons and may depend on advancements in technology, privacy protections, and an understanding of the limitations of genetic information.

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with Vaia!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Genetic Disorders Early Identification
The early identification of genetic disorders through newborn genome sequencing stands as a transformative advancement in neonatal care. By sequencing the DNA of newborns, healthcare providers can detect the presence of genetic anomalies that may lead to disorders before symptoms even manifest. This proactive approach facilitates early interventions, including lifestyle adjustments or medical treatments, that could significantly improve a child’s quality of life or even save it.

The implementation of such technologies could revolutionize the management of congenital conditions like cystic fibrosis or sickle cell anemia, where early treatment can have a profound impact. However, it is imperative to balance the potential health benefits against the risks of overdiagnosis and the emotional burden that may fall on families who learn of a predisposition to a genetic disorder with varying degrees of penetrance or expressivity.
Personalized Medicine
Personalized medicine represents a paradigm shift from the traditional 'one-size-fits-all' approach to a customized healthcare strategy. With newborn genome sequencing, physicians can personalize care from the earliest stages of life. Tailoring treatments to the individual's genetic makeup can increase the efficacy of medications, predict adverse drug reactions, and align preventative strategies to the patient’s unique profile.

For instance, when certain genetic mutations are identified, a patient can be guided away from drugs that would be ineffective or harmful. In the long term, personalized medicine may improve overall healthcare efficiency by avoiding trial-and-error prescribing, thus optimizing resource utilization. Despite these benefits, challenges such as equitably integrating personalized medicine into healthcare systems and ensuring all populations have access to such customized care must be navigated.
Preventative Healthcare Genetics
Bolstering preventative care through genetics, newborn genome sequencing has the potential to herald in a new era where genetic makeup informs healthcare strategies from day one. Understanding an individual’s genetic susceptibilities enables a proactive stance on health, empowering individuals with the knowledge they need to take control of their well-being through informed lifestyle choices and surveillance protocols.

Imagine the possibility of modifying diet or exposure to certain environmental factors to mitigate the risk of developing genetic-related diseases like type 2 diabetes or certain cancers. While the prospects are encouraging, the complex interplay between genes and environment also means that predictive accuracy may vary, and genetic predispositions do not always translate to certainties in developing a condition. Thus, a nuanced understanding of genetic risks is vital to prevent unnecessary alarm and ensure that preventative strategies are genuinely beneficial.
Ethical Issues in Genetics
The ethical landscape of genetics, especially regarding newborn genome sequencing, is rife with multifaceted dilemmas. The storage and use of genetic data raise serious privacy concerns. Who has access to this sensitive information, and how it may be used — potentially for discrimination in insurance or employment — is a significant worry.

Furthermore, the psychological implications for families receiving information about potential future health problems cannot be understated. Genetic counseling is essential to support informed decision-making and cope with the results. The necessity for robust ethical frameworks and transparent policies is paramount, as is the dialogue between the scientific community, ethicists, and the public to navigate these gray areas responsibly. As these technologies progress, it is critical that ethical considerations evolve in tandem to safeguard individual rights and societal values.

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

Dominant mutations can be categorized according to whether they increase or decrease the overall activity of a gene or gene product. Although a loss-of- function mutation (a mutation that inactivates the gene product) is usually recessive, for some genes, one dose of the normal gene product, encoded by the normal allele, is not sufficient to produce a normal phenotype. In this case, a loss-of-function mutation in the gene will be dominant, and the gene is said to be haploinsufficient. A second category of dominant mutation is the gain- of-function mutation, which results in a new activity or increased activity or expression of a gene or gene product. The gene therapy technique currently being used in clinical trials involves the "addition" to somatic cells of a normal copy of a gene. In other words, a normal copy of the gene is inserted into the genome of the mutant somatic cell, but the mutated copy of the gene is not removed or replaced. Will this strategy work for either of the two aforementioned types of dominant mutations?

Would you have your genome sequenced, if the price was affordable? Why or why not? If you answered yes, would you make your genome sequence publicly available? How might such information be misused?

Which of the examples of genetic testing below are prognostic tests? Which are diagnostic? (a) Individual sequencing (personal genomics) identifies a mutation associated with Alzheimer's disease. (b) ASO testing determines that an individual is a carrier for the mutant \(\beta\) -globin allele \(\left(\beta^{S}\right)\) found in sickle-cell anemia. (c) DNA sequencing of a breast tumor reveals mutations in the BRCA1 gene. (d) Genetic testing in a healthy teenager identifies an SNP correlated with autism. (e) An adult diagnosed with Asperger syndrome (AS) has a genetic test that reveals a SNP in the GABRB3 gene that is significantly more common in people with AS than the general population.

Why are most recombinant human proteins produced in animal or plant hosts instead of bacterial host cells?

A couple with European ancestry seeks genetic counseling before having children because of a history of cystic fibrosis (CF) in the husband's family. ASO testing for CF reveals that the husband is heterozygous for the \(\Delta 508\) mutation and that the wife is heterozygous for the \(R 117\) mutation. You are the couple's genetic counselor. When consulting with you, they express their conviction that they are not at risk for having an affected child because they each carry different mutations and cannot have a child who is homozygous for either mutation. What would you say to them?

See all solutions

Recommended explanations on Biology Textbooks

View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.

Sign-up for free